XML 64 R52.htm IDEA: XBRL DOCUMENT v3.21.2
Basis of Presentation - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Jun. 28, 2021
Jun. 17, 2021
Jan. 26, 2021
Nov. 17, 2020
Sep. 25, 2020
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Aug. 31, 2021
Aug. 28, 2020
Subsidiary, Sale of Stock [Line Items]                      
Net cash paid               $ 1,033,695,000 $ 68,920,000    
Payments of debt issuance costs               5,643,000 432,000    
Deferred compensation plan           $ 88,965,000 $ 50,000 89,327,000 (115,000)    
Net proceeds received               0 58,349,000    
Dividends payable (USD per share)                     $ 1.50
Dividends payable                     $ 392,489,000
Deferred Compensation Arrangement with Individual, by Type of Compensation, Pension and Other Postretirement Benefits | Nonqualified Plan                      
Subsidiary, Sale of Stock [Line Items]                      
Deferred compensation plan           88,965,000 $ 50,000 89,327,000 $ (115,000)    
Deferred Compensation Arrangement with Individual, by Type of Compensation, Pension and Other Postretirement Benefits | Nonqualified Plan | DCP, One-Time Inducement                      
Subsidiary, Sale of Stock [Line Items]                      
Reclassified cumulative compensation cost           4,739,000   4,739,000      
Deferred compensation plan           90,721,000   90,721,000      
Deferred compensation liability           $ 95,460,000   $ 95,460,000      
Seequent                      
Subsidiary, Sale of Stock [Line Items]                      
Net cash paid   $ 910,997,000                  
Class B Common Stock | Deferred Compensation Arrangement with Individual, by Type of Compensation, Pension and Other Postretirement Benefits | Nonqualified Plan                      
Subsidiary, Sale of Stock [Line Items]                      
Phantom shares, maximum elections (in shares)                   1,500,000  
Reduction in shares outstanding, basic (in shares)                   1,500,000  
Reduction in shares outstanding, diluted (in shares)                   1,500,000  
Class B Common Stock | Seequent                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares sold (in shares)   3,141,342                  
Class B Common Stock | Public Stock Offering - Shares From Existing Shareholders                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares sold (in shares)         12,360,991            
Price per share sold (USD per share)         $ 22.00            
Class B Common Stock | Follow-On Offering                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares sold (in shares)       11,500,000              
Price per share sold (USD per share)       $ 32.00              
Class B Common Stock | Follow-On Offering, Sold By Company                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares sold (in shares)       9,603,965              
Class B Common Stock | Follow-On Offering, Exercise By Underwriters                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares sold (in shares)       1,500,000              
Class B Common Stock | Follow-On Offering, Shares From Existing Shareholders                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares sold (in shares)       1,896,035              
Net proceeds received       $ 294,429,000              
Expenses associated with sale of stock       $ 12,898,000              
2026 Notes: | Convertible Debt                      
Subsidiary, Sale of Stock [Line Items]                      
Debt instrument, face amount     $ 690,000,000                
Debt instrument, interest rate, stated percentage     0.125%                
Payments of debt issuance costs     $ 18,055,000                
Payments of expenses associated with initial public offering     $ 25,530,000                
2027 Notes: | Convertible Debt                      
Subsidiary, Sale of Stock [Line Items]                      
Debt instrument, face amount $ 575,000,000                    
Debt instrument, interest rate, stated percentage 0.375%                    
Payments of debt issuance costs $ 15,065,000                    
Payments of expenses associated with initial public offering $ 25,875,000